About The Position

The CPS organization is seeking a Senior Director or Executive Director, Quality Enablement to provide enterprise-level leadership in defining, governing, and advancing quality oversight across early-phase and pharmacology studies. This role is critical to shaping CPS quality strategy and positioning quality as a strategic differentiator for sponsors. Job Overview This executive leader partners closely with CPS Executive Leadership and key cross-functional stakeholders—including Clinic Operations, Project Management, Data & Analytics, Quality, and Technology—to embed Quality by Design (QbD) and proactive, risk-based quality management into CPS study delivery models. The Senior/Executive Director is accountable for ensuring that CPS operational processes, standards, and training programs are fit-for-purpose, scalable, and inspection-ready , while fully aligned with global regulatory expectations. This role drives a forward-looking quality enablement framework that supports innovation, accelerates early-phase development, and strengthens sponsor confidence. As a strategic advisor to senior leadership, this individual influences enterprise decision-making, leads change at scale, and ensures consistent, high-quality execution across CPS environments.

Requirements

  • Bachelor’s degree required; advanced degree preferred. Fortrea may consider relevant and equivalent experience and successful project outcomes in lieu of educational requirements.
  • 10+ years of experience in clinical research, quality, or related fields (CRO, pharma, biotech).
  • 5+ years of progressive leadership experience in, quality management or process improvements, preferably within early‑phase or clinical pharmacology environments.
  • Demonstrated experience leading global, cross‑functional CPS teams and influencing senior stakeholders.
  • Extensive sponsor‑facing experience, including executive‑level interactions.
  • Strong understanding of CPS study designs, clinic operations, and early‑phase regulatory expectations.
  • Proven experience with audits, inspections, CAPA, and quality governance.
  • Deep expertise in quality enablement and CPS study execution
  • Strong executive presence with the ability to influence without authority
  • Advanced data analytics and risk signal interpretation capability
  • Strategic leadership combined with strong operational execution
  • Excellent communication, presentation, and stakeholder management skills
  • Change leadership and organizational transformation capability
  • Strong business and financial acumen within a CRO/CPS environment

Responsibilities

  • CPS Quality Enablement Strategy & Governance Define and own the CPS‑specific quality enablement strategy, ensuring alignment with Fortrea enterprise quality standards and regulatory guidance (FDA, EMA, ICH E6/E8 R1).
  • Establish quality enablement governance models, standards, and operating procedures tailored to CPS study designs, clinic‑based execution, and early‑phase risk profiles.
  • Serve as the senior escalation point for CPS portfoliolevel quality risks, protocol complexity, data integrity concerns, and inspection readiness issues.
  • Portfolio Oversight & Quality Assurance Provide oversight of quality enablement execution across the CPS clinical trial portfolio, including first‑in‑human, SAD/MAD, bioavailability, bioequivalence, and other clinical pharmacology studies.
  • Ensure consistent development, approval, and oversight of Integrated Quality Risk Management Plans (IQRMPs) strategies.
  • Review CPS‑level risk trends, KRIs, and performance indicators to drive proactive mitigation and continuous quality improvement.
  • Leadership & People Development Lead, coach, and develop quality enablement leaders and teams embedded within CPS, building sustainable capability across clinics and delivery teams.
  • Partner with CPS leadership on workforce planning, capability development, and succession planning related to quality and quality enablement roles.
  • Foster a culture of proactive risk ownership, accountability, and continuous improvement across CPS.
  • Cross‑Functional & Executive Partnership Act as a trusted advisor to CPS senior and executive leadership on quality enablement strategy, quality risk posture, and inspection readiness.
  • Collaborate with Clinic Operations, Project Management, Data Management, Biostatistics, Safety, and Quality to embed quality enablement into CPS delivery models.
  • Represent CPS in internal audits, sponsor audits, regulatory inspections, and governance forums.
  • Client Engagement & Business Development Serve as a senior CPS quality enablement representative in RFPs, RFIs, bid defenses, and sponsor governance meetings.
  • Articulate Fortrea’s CPS‑specific quality enablement value proposition, demonstrating differentiation in early‑phase quality oversight and execution.
  • Support complex sponsor discussions related to risk management, protocol complexity, data integrity, and inspection readiness.
  • Operational Excellence & Change Leadership Lead continuous improvement of CPS processes, tools, templates, and training materials.
  • Sponsor and lead change management initiatives to mature quality enablement adoption across CPS clinics and project teams.
  • Ensure CPS quality enablement knowledge management, lessons learned, and best practices are consistently captured and shared.
© 2024 Teal Labs, Inc
Privacy PolicyTerms of Service